Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Feb 15, 2024
Date Accepted: Jun 14, 2024

The final, peer-reviewed published version of this preprint can be found here:

Study of Postacute Sequelae of COVID-19 Using Digital Wearables: Protocol for a Prospective Longitudinal Observational Study

El-Toukhy S, Hegeman P, Zuckerman G, Das AR, Moses N, Troendle J, Powell-Wiley TM

Study of Postacute Sequelae of COVID-19 Using Digital Wearables: Protocol for a Prospective Longitudinal Observational Study

JMIR Res Protoc 2024;13:e57382

DOI: 10.2196/57382

PMID: 39150750

PMCID: 11364950

A prospective natural history study of post-acute sequelae of COVID-19 using digital wearables: Study protocol

  • Sherine El-Toukhy; 
  • Phillip Hegeman; 
  • Gabrielle Zuckerman; 
  • Anirban Roy Das; 
  • Nia Moses; 
  • James Troendle; 
  • Tiffany M. Powell-Wiley

ABSTRACT

Background:

Post-acute sequelae of COVID-19 (PASC) remains understudied in nonhospitalized patients. Digital wearables allow for a continuous collection of physiological parameters such as respiratory rate and oxygen saturation that have been predictive of disease trajectories in hospitalized patients.

Objective:

This protocol outlines the design and procedures of a natural history study of PASC that aims to identify wearables collected physiological parameters that are associated with PASC in patients with a positive diagnosis.

Methods:

This is a single-arm, prospective, natural history study of a cohort of 550 patients, ages 18 to 65 years old, males or females who own a smartphone and/or a tablet that meets pre-determined Bluetooth version and operating system requirements, speak English, and provide documentation of a positive COVID-19 test issued by a healthcare professional within 5 days before enrollment. The primary endpoint is long COVID-19, defined as ≥1 symptom at 3 weeks beyond first symptom onset or positive diagnosis, whichever comes first. The secondary endpoint is chronic COVID-19, defined as ≥1 symptom at 12 weeks beyond first symptom onset or positive diagnosis. Participants must be willing and able to consent to participate in the study and adhere to study procedures for six months.

Results:

The first patient was enrolled in October 2021.

Conclusions:

This is a fully decentralized study investigating PASC using wearable devices to collect physiological parameters and patient-reported outcomes. The study will shed light on the duration and symptom manifestation of PASC in nonhospitalized patient subgroups and is an exemplar of use of wearables as population-level monitoring health tools for communicable diseases. Clinical Trial: ClinicalTrials.gov NCT04927442


 Citation

Please cite as:

El-Toukhy S, Hegeman P, Zuckerman G, Das AR, Moses N, Troendle J, Powell-Wiley TM

Study of Postacute Sequelae of COVID-19 Using Digital Wearables: Protocol for a Prospective Longitudinal Observational Study

JMIR Res Protoc 2024;13:e57382

DOI: 10.2196/57382

PMID: 39150750

PMCID: 11364950

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.